Stock Events

Stock Events

Quantrx Biomedical 

$0.000500
6
+$0.00+0% Monday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.004
52W Low
0.00001
Volume
22,100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-260,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories competes in the diagnostics and medical devices sector, similar to Quantrx's focus on biomedical technologies.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company operates in the medical technology industry, offering products that compete with Quantrx's diagnostics solutions.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific provides analytical instruments and reagents, directly competing in the biomedical research market.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation's life sciences and diagnostics divisions offer products that overlap with Quantrx's market offerings.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, competing in the same niche as Quantrx.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories, Inc. provides clinical diagnostics and life science research products, competing in the diagnostics and research tools sector.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that could compete with Quantrx's diagnostic technologies.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences of California, Inc. offers sequencing systems that compete in the genomics and diagnostics field, relevant to Quantrx's interests.

About

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.
Show more...
CEO
Dr. Shalom Z. Hirschman M.D.
Country
United States
ISIN
US74765N1090

Listings

0 Comments

Share your thoughts

FAQ

What is Quantrx Biomedical stock price today?▼
The current price of QTXB is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Quantrx Biomedical stock price performance more closely on the chart.
What is Quantrx Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Quantrx Biomedical stocks are traded under the ticker QTXB.
What were Quantrx Biomedical earnings last quarter?▼
QTXB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quantrx Biomedical revenue for the last year?▼
Quantrx Biomedical revenue for the last year amounts to 0 USD.
What is Quantrx Biomedical net income for the last year?▼
QTXB net income for the last year is -260,000 USD.
In which sector is Quantrx Biomedical located?▼
Quantrx Biomedical operates in the Health & Wellness sector.
When did Quantrx Biomedical complete a stock split?▼
Quantrx Biomedical has not had any recent stock splits.
Where is Quantrx Biomedical headquartered?▼
Quantrx Biomedical is headquartered in Tualatin, United States.